Phase 3 Data Suggest Potential New Therapeutic Option for TNBC
Short-term results from the CamRelief phase 3 trial show that neoadjuvant camrelizumab (AiRuiKa) plus chemotherapy improves the rate of pathological…
Read article
Comparison of Paclitaxel Regimens in Early Breast Cancer Raises Questions
An analysis of the chemotherapy cohort from the ADAPT trial found that nanoparticle albumin-bound (nab)-paclitaxel (PAC) had similar outcomes to…
Sample New and Events
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…